NCT01587053终止不适用
Anti Vitamin K Therapeutic Education With INR Self Measure Device Within Children From 0 to 18 Years
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 57
- 试验地点
- 1
- 主要终点
- INR (International Normalized Ratio) time percentage in the target zone (TTR: time in therapeutic range)
研究概览
简要总结
The purpose of this study is to measure the INR (International Normalized Ratio) time percentage in the target zone (TTR: time in therapeutic range) of children benefiting from the AVK therapeutic education program.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 1 Day 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age from 0 to 18 years
- •AVK prescription
- •to accept participating to AVK therapeutic education program
- •informed consent form of parents or legal person
排除标准
- •parents or legal person refusal to enter in the AVK therapeutic education
结局指标
主要结局
INR (International Normalized Ratio) time percentage in the target zone (TTR: time in therapeutic range)
时间窗: up to 1 year
次要结局
- Quality of life questionnaire(2 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Daily Vitamin K in Patients on Warfarin With Unstable INRsAnticoagulantsWarfarinNCT00287313University of North Carolina, Chapel Hill15
Unknown
4 期
Comparison of Vitamin K Doses in Patients With Larger Burn InjuriesBurnsNCT03941535Joseph M. Still Research Foundation, Inc.50
已完成
不适用
A study to find the optimal dose for vitamin K supplementation in patients being treated with vitamin K antagonists to create an anti-coagulation effectISRCTN37109430etherlands Heart Foundation (Nederlandse Hartstichting) (The Netherlands)400
Unknown
不适用
Accuracy of a Portable International Normalized Ratio Monitor in Elderly PatientsBlood Coagulation DisordersBlood Coagulation Disorder With Prolonged Bleeding TimeBlood Coagulation Disorder With Prolonged Coagulation TimeNCT01930916University Hospital, Caen150
进行中（未招募）
不适用
A Study to see Levels of Vitamin MK-7 in blood and Stool Samples and microorganisms present in Stool Samples of Healthy SubjectsCTRI/2022/12/048578Synergia Life Sciences Pvt. Ltd. - A Novozymes One Health Company